Sue Fletcher

8.1k total citations · 1 hit paper
173 papers, 6.1k citations indexed

About

Sue Fletcher is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Sue Fletcher has authored 173 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 133 papers in Molecular Biology, 44 papers in Genetics and 23 papers in Genetics. Recurrent topics in Sue Fletcher's work include Muscle Physiology and Disorders (80 papers), RNA Interference and Gene Delivery (44 papers) and RNA Research and Splicing (35 papers). Sue Fletcher is often cited by papers focused on Muscle Physiology and Disorders (80 papers), RNA Interference and Gene Delivery (44 papers) and RNA Research and Splicing (35 papers). Sue Fletcher collaborates with scholars based in Australia, United States and United Kingdom. Sue Fletcher's co-authors include Steve D. Wilton, Jack Christopher, Kaite Honeyman, Lucy Barrett, Christopher J. Mann, Ianthe Pitout, Graham McClorey, Loren L. Flynn, P. Anthony Akkari and Karine Chenu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Sue Fletcher

170 papers receiving 6.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?

2019 517 citations Loren L. Flynn, Ianthe Pitout et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Sue Fletcher	4.3k	1.3k	937	897	519	173	6.1k
Bruce M. Paterson	5.9k 1.4×	936 0.7×	481 0.5×	497 0.6×	98 0.2×	56	8.7k
Xiaoxia Qi	10.6k 2.5×	922 0.7×	449 0.5×	242 0.3×	248 0.5×	48	13.4k
Matthew D. Rand	4.9k 1.1×	648 0.5×	476 0.5×	181 0.2×	247 0.5×	63	7.6k
Philippe Collas	8.5k 2.0×	1.6k 1.2×	1.3k 1.4×	475 0.5×	69 0.1×	226	10.7k
Lily Shiue	4.4k 1.0×	358 0.3×	682 0.7×	368 0.4×	776 1.5×	34	5.6k
Dirk Hockemeyer	8.2k 1.9×	1.3k 1.0×	367 0.4×	523 0.6×	276 0.5×	63	9.7k
Ronald G. Worton	4.4k 1.0×	1.2k 0.9×	667 0.7×	241 0.3×	55 0.1×	88	5.0k
Ronald Kriz	4.8k 1.1×	839 0.6×	425 0.5×	278 0.3×	97 0.2×	30	8.1k
Ke Ning	2.7k 0.6×	301 0.2×	683 0.7×	412 0.5×	343 0.7×	113	4.3k
Chad A. Cowan	10.1k 2.4×	1.6k 1.2×	569 0.6×	208 0.2×	140 0.3×	83	12.5k

Countries citing papers authored by Sue Fletcher

Since Specialization

Citations

This map shows the geographic impact of Sue Fletcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Fletcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Fletcher more than expected).

Fields of papers citing papers by Sue Fletcher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sue Fletcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Fletcher. The network helps show where Sue Fletcher may publish in the future.

Co-authorship network of co-authors of Sue Fletcher

This figure shows the co-authorship network connecting the top 25 collaborators of Sue Fletcher. A scholar is included among the top collaborators of Sue Fletcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sue Fletcher. Sue Fletcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mastaglia, Frank, et al.. (2025). Expression and Site-Specific Biotinylation of Human Cytosolic 5′-Nucleotidase 1A in Escherichia coli. Methods and Protocols. 8(3). 66–66.

Fletcher, Sue, et al.. (2024). Limb Girdle Muscular Dystrophy Type 2B (LGMD2B): Diagnosis and Therapeutic Possibilities. International Journal of Molecular Sciences. 25(11). 5572–5572. 2 indexed citations

Pitout, Ianthe, Fred K. Chen, Samuel McLenachan, et al.. (2024). A Precision Therapy Approach for Retinitis Pigmentosa 11 Using Splice-Switching Antisense Oligonucleotides to Restore the Open Reading Frame of PRPF31. International Journal of Molecular Sciences. 25(6). 3391–3391. 5 indexed citations

Larcher, Leon M., et al.. (2023). DNAzymes: Expanding the Potential of Nucleic Acid Therapeutics. Nucleic Acid Therapeutics. 33(3). 178–192. 27 indexed citations

Charoensawan, Varodom, et al.. (2022). Antisense Oligonucleotide Induction of the hnRNPA1b Isoform Affects Pre-mRNA Splicing of SMN2 in SMA Type I Fibroblasts. International Journal of Molecular Sciences. 23(7). 3937–3937. 1 indexed citations

Fletcher, Sue, et al.. (2021). Proof-of-Concept: Antisense Oligonucleotide Mediated Skipping of Fibrillin-1 Exon 52. International Journal of Molecular Sciences. 22(7). 3479–3479. 3 indexed citations

Flynn, Loren L., Chalermchai Mitrpant, A.M. Adams, et al.. (2021). Targeted SMN Exon Skipping: A Useful Control to Assess In Vitro and In Vivo Splice-Switching Studies. Biomedicines. 9(5). 552–552. 4 indexed citations

McLenachan, Samuel, Dan Zhang, Xiao Zhang, et al.. (2021). Determinants of Disease Penetrance in PRPF31-Associated Retinopathy. Genes. 12(10). 1542–1542. 15 indexed citations

Jeffery, Rachael C. Heath, May T. Aung-Htut, Samuel McLenachan, et al.. (2021). Stargardt disease and progress in therapeutic strategies. Ophthalmic Genetics. 43(1). 1–26. 27 indexed citations

10.

Fletcher, Sue, et al.. (2021). A spotter’s guide to SNPtic exons: The common splice variants underlying some SNP–phenotype correlations. Molecular Genetics & Genomic Medicine. 10(1). e1840–e1840. 4 indexed citations

11.

Li, Ruohan, et al.. (2020). NEAT1 polyA-modulating antisense oligonucleotides reveal opposing functions for both long non-coding RNA isoforms in neuroblastoma. Cellular and Molecular Life Sciences. 78(5). 2213–2230. 46 indexed citations

12.

Thompson, Jennifer A., Jason Charng, Samuel McLenachan, et al.. (2020). Phenotype–genotype correlations in a pseudodominant Stargardt disease pedigree due to a novel ABCA4 deletion–insertion variant causing a splicing defect. Molecular Genetics & Genomic Medicine. 8(7). e1259–e1259. 11 indexed citations

13.

Li, Dunhui, Frank Mastaglia, Sue Fletcher, & Steve D. Wilton. (2020). Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine era. Medicinal Research Reviews. 40(6). 2650–2681. 39 indexed citations

14.

Aung-Htut, May T., et al.. (2019). Systematic Approach to Developing Splice Modulating Antisense Oligonucleotides. International Journal of Molecular Sciences. 20(20). 5030–5030. 15 indexed citations

15.

Flynn, Loren L., Chalermchai Mitrpant, Ianthe Pitout, Sue Fletcher, & Steve D. Wilton. (2018). Antisense Oligonucleotide-Mediated Terminal Intron Retention of the SMN2 Transcript. Molecular Therapy — Nucleic Acids. 11. 91–102. 17 indexed citations

16.

Callus, Bernard A., Megan Finch‐Edmondson, Sue Fletcher, & Steve D. Wilton. (2018). YAPping about and not forgetting TAZ. FEBS Letters. 593(3). 253–276. 26 indexed citations

17.

Li, Dunhui, Frank Mastaglia, Sue Fletcher, & Steve D. Wilton. (2018). Precision Medicine through Antisense Oligonucleotide-Mediated Exon Skipping. Trends in Pharmacological Sciences. 39(11). 982–994. 58 indexed citations

18.

Rice, Emily, Roberto A. Barrero, M. Bellgard, et al.. (2015). Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient. Molecular Genetics & Genomic Medicine. 3(4). 320–326. 22 indexed citations

19.

Viola, Helena M., A.M. Adams, Stefan M.K. Davies, et al.. (2014). Impaired functional communication between the L-type calcium channel and mitochondria contributes to metabolic inhibition in the mdx heart. Proceedings of the National Academy of Sciences. 111(28). E2905–14. 43 indexed citations

20.

Honeyman, Kaite, et al.. (1999). Development of a snapback method of single-strand conformation polymorphism analysis for genotyping Golden Retrievers for the X-linked muscular dystrophy allele. American Journal of Veterinary Research. 60(6). 734–737. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact